A new trial concludes that bovine colostrum (COL) can reduce risk of upper respiratory tract infections (URTIs) in non-athletic adults at heightened risk of infection, adding to a body of research previously concentrating on athletes.
Chinese infants consuming milk formulas containing Bifidobacterium animalis subsp. lactis HN019 reported a lower rate of upper respiratory tract infections compared to those who drank formulas containing another probiotic strain, or no probiotics at all,...
Chinese researchers linked probiotic supplementation to fewer incidence of flu-like symptoms in new study, building the science backing probiotics’ benefits to the upper respiratory tract.
Delivering nutrients to different age groups isn’t just about market research on format preferences—clinical studies should also be involved, according to R&D and brand specialists at ingredient giant Kerry.
German OTC health products manufacturer Pohl-Boskamp is bringing a respiratory health supplement to the US market after decades of market history in the EU.
A combination of Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABLA-12 may reduce the severity and duration of respiratory infections in children, says a new study.
Daily probiotic supplements may reduce the incidence of gastrointestinal and upper respiratory tract infections for professional rugby players, says a new study from New Zealand.
Daily supplements of the probiotic Bifidobacterium lactis subsp lactis Bl-04 may reduce the risk of the common cold (upper respiratory tract infections or URTIs) in active adults, says a new study from Australia.
The European Food Safety Authority (EFSA) has rejected a 13.5 health claim linking Leiber’s beta glucan Yestimun to defence against the common cold, but the company is gearing up for another application after claiming the regulator has been inconsistent.
Yakult failed to present the most basic evidence and sought a too-complicated immunity claim in the controversially rejected immunity health claim for its probiotic drinks, a UK consultant has said.
The author of a high-profile study suggesting that a daily Yakult dose could reduce the incidence and severity of upper respiratory tract infection (URTI) has hit back at criticism of his paper by EFSA (the European Food Safety Authority).
Japanese probiotics giant Yakult says its recent EFSA probiotic health claim rejection discounted peer-review validated respiratory tract health measures, and called on the European Commission to facilitate a discussion on the matter.
Daily supplements with probiotic Lactobacillus strains may reduce the incidence of acquiring the common cold by 12 percent, according to new research from probiotic player Probi.
Supplements of quercetin may cut the number of sick days linked to respiratory infections, but the effects are not shared by all age groups, according to new research.
Lactobacillus GG (LGG) can decrease the risk of upper respiratory tract infections including rhinitis, pharyngitis, sinusitis, otitis, and the common cold in children attending day care centres, claims a new study.
A syrup made with the popular herb echinacea reduced the number of
respiratory tract infections in children but did not reduce the
severity or duration of infections, report authors of a new
clinical trial in today's Journal...
Contrary to widely held views, giving iron supplements to anaemic
children when they have a cold or other upper respiratory tract
infection can improve their iron status without side effects, finds
a recent study.
